Clinical Trial Update: Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing single-agent versus combination chemotherapy in high-risk elderly patients with non-small cell lung cancer was terminated. Results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Yale University | Conditions: Carcinoma, Non-small Cell Lung | Phase 2 | Status: TERMINATED | Results posted: 2018-02-28